Literature DB >> 29079469

Reprogramming energetic metabolism in Alzheimer's disease.

Alexandre Vallée1, Yves Lecarpentier2, Rémy Guillevin3, Jean-Noël Vallée4.   

Abstract

Entropy rate is increased by several metabolic and thermodynamics abnormalities in neurodegenerative diseases (NDs). Changes in Gibbs energy, heat production, ionic conductance or intracellular acidity are irreversibles processes which driven modifications of the entropy rate. The present review focusses on the thermodynamic implications in the reprogramming of cellular energy metabolism enabling in Alzheimer's disease (AD) through the opposite interplay of the molecular signaling pathways WNT/β-catenin and PPARγ. In AD, WNT/β-catenin pathway is downregulated while PPARγ is upregulated. Thermodynamics behaviors of metabolic enzymes are modified by dysregulation of the canonical WNT/β-catenin pathway. Downregulation of WNT/β-catenin pathway leads to oxidative stress and cell death through inactivation of glycolytic enzymes such as Glut, PKM2, PDK1, MCT-1, LDH-A but activation of PDH. In addition, in NDs, PPARγ is dysregulated whereas it contributes to the regulation of several key circadian genes. AD is considered as a dissipative structure that exchanges energy or matter with its environment far from the thermodynamic equilibrium. Far-from-equilibrium thermodynamics are notions driven by circadian rhythms. Circadian rhythms directly participate in regulating the molecular pathways WNT/β-catenin and PPARγ involved in the reprogramming of cellular energy metabolism enabling AD processes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; PPARγ; WNT/β-catenin pathway; circadian rhythms; inflammation; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 29079469     DOI: 10.1016/j.lfs.2017.10.033

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

Review 2.  WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer's Disease.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Yves Lecarpentier
Journal:  Curr Hypertens Rep       Date:  2022-07-05       Impact factor: 4.592

Review 3.  Arterial Stiffness and the Canonical WNT/β-catenin Pathway.

Authors:  Alexandre Vallée
Journal:  Curr Hypertens Rep       Date:  2022-06-21       Impact factor: 4.592

Review 4.  Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Mol Psychiatry       Date:  2021-04-09       Impact factor: 15.992

Review 5.  Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Int J Mol Sci       Date:  2018-04-16       Impact factor: 5.923

6.  Intravenous Bone Marrow Mononuclear Cells Transplantation in Aged Mice Increases Transcription of Glucose Transporter 1 and Na+/K+-ATPase at Hippocampus Followed by Restored Neurological Functions.

Authors:  Yukiko Takeuchi; Yuka Okinaka; Yuko Ogawa; Akie Kikuchi-Taura; Yosky Kataoka; Sheraz Gul; Carsten Claussen; Johannes Boltze; Akihiko Taguchi
Journal:  Front Aging Neurosci       Date:  2020-06-11       Impact factor: 5.750

Review 7.  Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rodolphe Vallée; Rémy Guillevin; Jean-Noël Vallée
Journal:  Int J Mol Sci       Date:  2020-01-27       Impact factor: 5.923

8.  Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Aging (Albany NY)       Date:  2020-02-08       Impact factor: 5.682

Review 9.  The influence of circadian rhythms and aerobic glycolysis in autism spectrum disorder.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Transl Psychiatry       Date:  2020-11-16       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.